Publications

Gantner A, Labuhn S, Furst D, Mannes S, Flossdorf S, Ayuk FA, Schroeder T, Stelljes M, Zeiser R, Dreger P, Eder M, Blau IW, Schetelig J, Brecht A, Burchert A, Edinger M, Wais V, Schrezenmeier H, Dohner H, Schmeller S, Fleischhauer K, Kroger N, Sala E, German Registry for Hematopoietic Stem Cell T, cell Therapy D. Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignancies. Bone Marrow Transplant. 2026 Jun. 61:694–701. doi:10.1038/s41409-026-02827-y. PMID: 41951842

Stoner SN, Larson ED, Fulte S, Shaw SC, Fish ER, Janoff EN, Mack M, Clark SE. Myeloid cell reprogramming drives enhanced defense against Streptococcus pneumoniae lung infection following exposure to commensal Prevotella. bioRxiv. 2026 Jun 25. doi:10.64898/2026.06.25.734552. PMID: 42395429

Porenta D, Benne N, Sijts A, Broere F, Mastrobattista E. Induction of SpCas9-Directed Immune Responses Using Lipid Nanoparticles and Identification of SpCas9-Derived T Cell Epitopes in C57BL/6 Mice. CRISPR J. 2026 Jun. 9:151–166. doi:10.1177/25731599261456887. PMID: 42299032

Wekerle T, Muckenhuber M, Heinzel A, Weijler AM, David AF, Kainz V, Hu K, Mucha J, Mengrelis K, Reindl-Schwaighofer R, Bohmig GA, Watschinger B, Gyori G, Soliman T, Salat A, Schwarz C, Muhm M, Heinze G, Wolzt M, Worel N, Fortschegger M, Lion T, Regele H, Berlakovich G, Halloran PF et al. Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation. Sci Transl Med. 2026 Jun 17. 18:eaee6850. doi:10.1126/scitranslmed.aee6850. PMID: 42308328

Knelangen N, Bader U, Maniaki E, Engels B, Gattinoni L, Mittelstaet J. Transcriptional and functional profiling reveals unique activation of Adapter CAR T cells in acute myeloid leukemia. J Transl Med. 2026 Jun 18. 24doi:10.1186/s12967-026-08461-y. PMID: 42316369

Schlierkamp-Voosen T, Barden M, Janning H, Kaljanac M, Harrer DC, Dreger C, Hammon K, Ertelt M, Schoeder CT, Halldorsdottir HR, Rodriguez-Pardo C, Hadrup SR, Thomas S, Abken H. Blocking CD30 on CD19 CAR T cells augments their functional capacities against B-cell leukemia/lymphoma. Front Immunol. 2026 17:1725641. doi:10.3389/fimmu.2026.1725641. PMID: 42148107

Soares MVD, Gomez VE, Azevedo RI, Pereira PNG, Velazquez TC, Mendes L, Alho AC, Garcia-Guerrero E, Garcia-Calderon CB, Tharmaratnam K, Cabral IA, Ribeiro AC, Juncal C, Roncon S, Pais AT, Gil AR, Espada E, Rodrigues A, Garcao A, Yaspo ML, Warnatz HJ, Lehrach H, Ward L, Barbosa-Morais NL, Quintas AM et al. Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease. Blood Adv. 2026 May 12. 10:2904–2915. doi:10.1182/bloodadvances.2025017996. PMID: 41637631

Mast AS, Lang P, Schlegel P, Calkoen FG, Atar D, Scheuermann S, Klein S, Braun C, Schinle F, Schmidt M, Hensen L, Ebinger M, Doring M, Schafer JF, Schulte J, Bethge WA, Lengerke C, Alahmari B, Hu P, Schneider D, Orentas RJ, Handgretinger R, Seitz CM. Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort. J Immunother Cancer. 2026 May 21. 14doi:10.1136/jitc-2025-013901. PMID: 42167809

Huerta Arana M, Klapproth H, Stanczak MA, Bopp L, Witschurke K, Seitz R, Lopez Martinez M, Zamek J, Henschke S, Rana N, O’Sullivan D, Steinkamp J, Lackmann JW, Damsky W, von Stebut E, Sanin DE, Zigrino P, Klein Geltink RI, Pearce EJ, Pearce EL, Fabri M. A STAT1/ETC/GBP1 axis represents a potential therapeutic target for noncommunicable granulomatous skin disease. Sci Adv. 2026 May 29. 12:eaea0773. doi:10.1126/sciadv.aea0773. PMID: 42213834

Gryksa K, Sibilia M, Rothhammer V, Liston A, Zaiss DM. The Epidermal Growth Factor Receptor (EGFR) as a means of neuro-immune cross-conversation. J Neuroinflammation. 2026 May 21. 23doi:10.1186/s12974-026-03873-5. PMID: 42169107